Biostate AI (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Artificial Intelligence / Molecular Diagnostics
- Funding URL
- View Funding Page
- Funding Amount:
- $12,000,000
Company Info
- Traction
- Biostate has run RNAseq on over 10,000 samples from over 150 collaborators and customers from leading institutions and secured agreements to process several hundred thousand unlabeled samples annually.
- Organizations Involved
- Cornell, Accelerated Cure Project
- Founders
- David Zhang, Ashwin Gopinath
- Company Description
- Biostate AI is a startup building generative AI that predicts the evolution of human disease and drug response based on RNA sequencing data. Its patented wetlab technologies, including BIRT, allow affordable and scalable collection of massive amounts of transcriptomic and genomic data.
- Market
- Molecular Research / Precision Medicine
- Location
- Houston, Texas, USA
- Coinvestors
- Accel, Gaingels, Mana Ventures, InfoEdge Ventures, Matter Venture Partners, Vision Plus Capital, Catapult Ventures, Dario Amodei, Mike Schnall-Levin, Emily Leproust